ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,239, issued on Sept. 29, was assigned to United States Government As Represented By The Department of Veterans Affairs (Washington).
"Compositions and methods comprising endothelin a receptor antagonists androgen therapies" was invented by Gregory A. Clines (Ann Arbor, Mich.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compositions comprising an endothelin A receptor (ETAR) antagonist, an anti-androgen therapy, and chemical castration therapy. Also disclosed are compositions comprising an ETAR antagonist, copackaged or coformulated with an anti-androgen therapy. Disclosed are methods of preventing prostate cancer metastasis comprisi...